These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4587820)

  • 1. Generation times of Proteus mirabilis and Escherichia coli in experimental infections.
    Eudy WW; Burrous SE
    Chemotherapy; 1973; 19(3):161-70. PubMed ID: 4587820
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli.
    Girlich D; Karim A; Spicq C; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):893-5. PubMed ID: 11152321
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli.
    Lane MC; Li X; Pearson MM; Simms AN; Mobley HL
    J Bacteriol; 2009 Mar; 191(5):1382-92. PubMed ID: 19114498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of bacterial adherence in urinary tract infections].
    Gromska W
    Postepy Hig Med Dosw; 1985; 39(3):245-63. PubMed ID: 2870490
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of purple urine bag syndrome (PUBS).
    Röggla G; Kapiotis S; Fahrner A
    Wien Klin Wochenschr; 2002 May; 114(8-9):306. PubMed ID: 12212364
    [No Abstract]   [Full Text] [Related]  

  • 6. THE FATE OF PSEUDOMONAS AERUGINOSA, PROTEUS MIRABILIS AND ESCHERICHIA COLI IN THE MOUSE KIDNEY.
    GORRILL RH
    J Pathol Bacteriol; 1965 Jan; 89():81-8. PubMed ID: 14263500
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.
    Nakamura T; Komatsu M; Yamasaki K; Fukuda S; Miyamoto Y; Higuchi T; Ono T; Nishio H; Sueyoshi N; Kida K; Satoh K; Toda H; Toyokawa M; Nishi I; Sakamoto M; Akagi M; Nakai I; Kofuku T; Orita T; Wada Y; Zikimoto T; Koike C; Kinoshita S; Hirai I; Takahashi H; Matsuura N; Yamamoto Y
    Am J Clin Pathol; 2012 Apr; 137(4):620-6. PubMed ID: 22431539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinoxacin: effectiveness against experimental pyelonephritis in rats.
    Holmes DH; Ensminger PW; Gordee RS
    Antimicrob Agents Chemother; 1974 Oct; 6(4):432-6. PubMed ID: 4157340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afebrile emphysematous pyelonephritis.
    Chung SD
    Int J Infect Dis; 2008 Nov; 12(6):e161. PubMed ID: 18550410
    [No Abstract]   [Full Text] [Related]  

  • 10. Different binding specificities of P. mirabilis compared to E. coli.
    Lomberg H; Larsson P; Leffler H; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():37-42. PubMed ID: 6753134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
    Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
    Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumoureter.
    Chung SD; Sun HD; Weng WC; Chiu B; Peng FS
    Int J Infect Dis; 2009 Mar; 13(2):e79-80. PubMed ID: 19254678
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of media containing chromogenic substrates for the identification and the listing of urinary bacteria].
    Martin C; Orenga S; Doleans F; Denis F
    Pathol Biol (Paris); 1995 Nov; 43(9):749-53. PubMed ID: 8746095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection.
    Jacobsen SM; Lane MC; Harro JM; Shirtliff ME; Mobley HL
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):180-93. PubMed ID: 18194341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pathogenicity factors of the opportunistic bacteria that cause diarrhea].
    Khmelevskaia GV; Devterova LV; Iagovkin EA; Shepelev AP; Martynenko LD
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):97-102. PubMed ID: 2201150
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute obstructive pyelonephritis (experimental research)].
    Rubtsov IuS
    Urol Nefrol (Mosk); 1986; (4):22-4. PubMed ID: 3532486
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity of Proteus mirabilis strains to the bactericidal action of human serum].
    Frolov AF; Parkhomenko LV; Lukach IG
    Mikrobiol Zh (1978); 1986; 48(3):23-6. PubMed ID: 3077431
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of size limitation of bacterial colonies.
    Hochberg MS; Folkman J
    J Infect Dis; 1972 Dec; 126(6):629-35. PubMed ID: 4577424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protective effect of coli-proteus vaccine in an experimental animal model].
    Bĕlohlávek S; Konícková L
    Cesk Farm; 1980 May; 29(3-4):95-9. PubMed ID: 6996844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.